Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine

Published:2023-05-18 Issue:7 Volume:29 Page:655-664
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Ren Xue-yu,Li Ying-fei,Liu Hui-qing,Lin Hui,Lin Qian,Wu Yang,Wan Jie,Lu Jin-jin,Liu Jing,Cui Xiao-yun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-023-3638-8.pdf

Reference70 articles.

1. Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics—2021 update a report from the American Heart Association. Circulation 2021;143:e254–e743.

2. Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med 2017;376:2053–2064.

3. Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289–1367.

4. Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39:119–177.

5. Byrne RA, Stone GW, Ormiston J, et al. Coronary balloon angioplasty, stents, and scaffolds. Lancet 2017;390:781–792.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing of <italic>PCK1</italic> mitigates the proliferation and migration of vascular smooth muscle cells and vascular intimal hyperplasia by suppressing STAT3/DRP1-mediated mitochondrial fission;Acta Biochimica et Biophysica Sinica;2024-09-01

2. Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models;American Journal of Translational Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3